Moreover, in NSCLC, apatinib has been observed to induce the generation of ROS, suppress the expression of Nrf2 and p62, trigger autophagy and apoptosis, and inhibit tumor proliferation, both in vitro and in vivo141. Here, NFE2L2 is linked to non-small cell lung carcinoma.